Novo Nordisk A/S: all 1,444 studies

Page 1 of 15. Open to participants first (108), then studies with results posted, then the rest; newest registration first within each.

• A Research Study to Check the Safety of NNC9836-0001 When Given to Healthy Participants and Participants With Type 2 DiabetesNot yet recruitingNCT07896109Phase 1
• Semaglutide Health Outcomes and Patient Adherence in AustraliaNot yet recruitingNCT07881770
• A Research Study Investigating How Adults With Overweight or Obesity, With or Without Type 2 Diabetes, Tolerate Switching to a New Treatment (Zenagamtide) From Their Current Tirzepatide MedicationRecruitingNCT07868354Phase 1
• A Research Study to Look at How Well Zenagamtide Works Compared to Placebo in People With Established Atherosclerotic Cardiovascular Disease and Either Overweight or ObesityNot yet recruitingNCT07861100Phase 3
• A Research Study Investigating How Adults With Overweight or Obesity, With or Without Type 2 Diabetes, Tolerate Switching to a New Treatment (Zenagamtide) From Their Current Semaglutide MedicationRecruitingNCT07855133Phase 1
• A Research Study Looking Into How a High Dose of s.c. Semaglutide Works With Emptying of the Stomach in People With Excess Body WeightNot yet recruitingNCT07845578Phase 1
• A Research Study Investigating Denecimig (Mim8) in Adults With Acquired Haemophilia ANot yet recruitingNCT07830732Phase 3
• A Study to See How Safe a New Medicine (NNC0642-1895) is in Healthy PeopleRecruitingNCT07829406Phase 1
• AMAZE 10: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People in Japan With Excess Body Weight Lose WeightRecruitingNCT07822061Phase 3
• Research Study on How People With Type 2 Diabetes Tolerate Switching From Semaglutide to CagrisemaRecruitingNCT07817251Phase 3
• A Research Study Looking at the Effect of Timing of Meal After Dosing and Water Volume at Dosing on How the Medicine Zenagamtide is Taken up by the Body of Participants With Overweight or ObesityRecruitingNCT07815067Phase 1
• A Research Study Looking Into How a Single Dose of the Medicine NNC0537-1482 Moves Through the Body of Participants With Normal or Reduced Kidney FunctionNot yet recruitingNCT07808788Phase 1
• A Study to See How Safe a New Medicine (NNC0705-0002) is in Healthy PeopleRecruitingNCT07797855Phase 1
• AMBITION 7: A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Insulin Glargine in People With Type 2 Diabetes and Increased Risk of Diseases That Affect the Heart and Blood Vessels Treated With 1-3 Other Diabetes MedicationsRecruitingNCT07797335Phase 3
• Research Study on How Well Oral Semaglutide Works for Weight Loss in Adults With Excess Body WeightRecruitingNCT07770841Phase 3
• Study to Assess Tolerability of Injecting Larger Volumes (2-5 mL) Subcutaneously at Different Rates: Participant Experience and AcceptanceRecruitingNCT07769489Phase 1
• A First-in-human Research Study on How NNC0721-8060 Works in People Living With Overweight or ObesityRecruitingNCT07767175Phase 1
• A Research Study to See How NNC0487-0111 Affects the Body's Energy Use After a Weight Loss in Adults Living With Overweight or Obesity, Compared to a Low-calorie Diet or PlaceboRecruitingNCT07757087Phase 1
• A Research Study to Compare Two Different Versions of Injectable Cagrilintide and Placebo in People With Excess Body WeightRecruitingNCT07745504Phase 3
• AMAZE 9: A Research Study Investigating How Well Zenagamtide Tablets Help People With Excess Body Weight Lose WeightRecruitingNCT07720271Phase 3
• Database Linkage Study to Evaluate the Risk of Medullary Thyroid CarcinomaEnrolling by invitationNCT07713901
• A Research Study on How UBT251 Affects Levels of Midazolam, Caffeine and Warfarin in the Blood of Participants With Excess Body WeightRecruitingNCT07710768Phase 1
• A Research Study Looking Into How UBT251 Works With Birth Control Tablets and Emptying of the Stomach in Women With Excess Body Weight Not Able to Become PregnantRecruitingNCT07710729Phase 1
• A Study to See How Safe a New Medicine (NNC6022-0004) is in Healthy People and People Living With ObesityRecruitingNCT07693868Phase 1
• Management Concepts of Metabolic Dysfunction Associated Steatotic Liver Disease (MASLD) Among Chinese PhysiciansRecruitingNCT07682363
• Prevalence and Overlap of Cardiovascular, Kidney, and Metabolic Diseases in Korea: A Population-based StudyEnrolling by invitationNCT07673822
• A Research Study Investigating How Well the Medicine Zenagamtide Helps People With Excess Body Weight Lose Weight Compared to SemaglutideRecruitingNCT07668414Phase 3
• AMAZE 13: A Research Study Investigating How Well the Medicine Zenagamtide Helps People in Asia With Excess Body Weight Lose WeightNot yet recruitingNCT07668401Phase 3
• A Research Study Comparing How Well Different Doses of the Medicine UBT251 Lower Blood Sugar in People With Type 2 DiabetesRecruitingNCT07668388Phase 2
• Research Study to Examine Blood Sugar Control, Treatment Satisfaction and Adherence in People With Type 2 Diabetes After Switching From Daily Basal Insulin to Once-weekly Insulin IcodecEnrolling by invitationNCT07658417
• A Study Understanding How Much CDR132L Enters the Bloodstream After Injection Under the Skin Compared to Injection Into a Vein in Healthy ParticipantsRecruitingNCT07656454Phase 1
• Patient Preferences in Treatment of Haemophilia A With and Without Inhibitors: a Discrete Choice Experiment in GermanyEnrolling by invitationNCT07653139
• A Research Study to Examine Blood Sugar Control, Treatment Satisfaction and Adherence in People With Type 2 Diabetes After Switching From Daily Basal Insulin to Once-weekly Insulin IcodecEnrolling by invitationNCT07632404
• Evaluation of the Tolerability of Cagrilintide in Participants Not Tolerating GLP-1-RA Therapies Due to Gastrointestinal Adverse EventsRecruitingNCT07607587Phase 1
• A Research Study to Compare Blood Levels of Cagrilintide After Multiple Doses of Different Versions of Cagrilintide in Adults With Overweight or ObesityRecruitingNCT07597018Phase 1
• A Research Study Looking Into Blood Levels of the Medicine NNC0487-0111 in the Body and How Well it is Tolerated in People With Reduced Liver Function and Normal Liver FunctionNot yet recruitingNCT07587710Phase 1
• A Research Study Investigating the Effect of NNC0497-0040 in Healthy Participants, Participants With Overweight or Obesity, and Participants With Type 1 Diabetes With Overweight or ObesityRecruitingNCT07578584Phase 1
• AMAZE 4: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Treated With Positive Airway Pressure Lose Weight and Improve Sleep ApnoeaRecruitingNCT07571109Phase 3
• AMAZE 3: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Not Treated With Positive Airway Pressure Lose Weight and Improve Sleep ApnoeaRecruitingNCT07571005Phase 3
• A Research Study to Evaluate the Safety of NNC1679-0001 When Given to Healthy Participants and Participants With T2DMRecruitingNCT07570992Phase 1
• A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and ObesityRecruitingNCT07567001Phase 3
• A Research Study Investigating How a New Medicine NNC0113-5840 Works in People With Overweight or ObesityRecruitingNCT07566390Phase 1
• A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose WeightRecruitingNCT07564414Phase 3
• A Research Study Looking Into How Cagrilintide Influences Food Intake and Appetite in People With Overweight or ObesityRecruitingNCT07557953Phase 1
• Investigating How NNC0487-0111 Regulates Insulin of Adults With Type 2 DiabetesRecruitingNCT07535307Phase 1
• AMAZE 2: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Type 2 Diabetes Lose WeightRecruitingNCT07533175Phase 3
• A Real-world Study to Investigate Cardiovascular Risk Profile Among Newly Diagnosed Type 2 Diabetes Mellitus (T2DM) ParticipantsRecruitingNCT07532863
• Understanding the Effect of CagriSema, Cagrilintide, and Semaglutide on Muscle Health (Role of Amylin Signature in Muscle Health)RecruitingNCT07527195Phase 1
• AMAZE 6: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoarthritis Lose Weight and Reduce PainRecruitingNCT07509307Phase 3
• A Research Study Looking at How NNC0487-0111 Affects Food Intake, Appetite and Metabolism After Meals in People With ObesityRecruitingNCT07508020Phase 1
• A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoarthritis Lose Weight and Reduce PainRecruitingNCT07481630Phase 3
• A Two-armed Real-world Study of Ozempic (OW Semaglutide) to Evaluate Its Adherence and Persistence Compared With Other Anti-diabetic Drugs Among Adult T2DM Patients in ChinaEnrolling by invitationNCT07456774
• A Research Study to Look at the Distribution and Effects of Coramitug on Amyloid Deposits in Heart Tissue Using PET/CT Imaging in People With ATTR Amyloidosis.RecruitingNCT07448623Phase 1
• A Study to See How Safe a New Medicine (NNC6989-0001) is in Healthy People Living With Overweight or ObesityRecruitingNCT07437079Phase 1
• A Research Study Comparing How Well Different Doses of the Medicine NNC0662-0419 Lower Blood Sugar in People With Type 2 DiabetesRecruitingNCT07415954Phase 2
• A Study Looking at How Weekly Injections of Two Hormones - GIP and Amylin - Affect Stomach-related Side Effects in People Who Are Overweight or ObeseRecruitingNCT07411560Phase 1
• AMAZE 8: A Research Study Investigating How Well the Medicine NNC0487-0111 Compared to Semaglutide Helps People With Excess Body Weight and Type 2 Diabetes Lose WeightNot yet recruitingNCT07400107Phase 3
• A Research Study on How Well Different Doses of the Medicine UBT251 Help People Living With Overweight or ObesityRecruitingNCT07395687Phase 2
• AMAZE 1: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight Lose WeightRecruitingNCT07339423Phase 3
• A Research Study to Look at the Effect of Ziltivekimab on Plaque in the Blood Vessels of the Heart, Compared to Placebo, in People With a Heart AttackRecruitingNCT07301034Phase 3
• A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Placebo in Children and Adolescents With Type 2 DiabetesRecruitingNCT07282613Phase 3
• WEgovy Real World Assessment of Weight Loss in KoreaEnrolling by invitationNCT07280221
• A Research Study of a New Medicine, NNC9733-0001, in Healthy Participants and Participants With Type 2 DiabetesRecruitingNCT07270731Phase 1
• A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body WeightRecruitingNCT07253285Phase 3
• Examination of How the Duration of Fasting and Temporary Stopping of GLP-1 Medications Affect the Amount of Food Left in the Stomach in People Using Liraglutide (Injected), Semaglutide (Taken by Mouth) or Semaglutide (Injected)RecruitingNCT07225816Phase 1
• A Research Study Looking at How Different Doses of Study Medicine (Inno8) Work in the Body of People With Haemophilia ARecruitingNCT07220564Phase 1
• A Research Study on the Effects of NNC0537-1482 in Participants With Heart FailureRecruitingNCT07218627Phase 1
• CLEOPATTRA: A Research Study to Look at the Effects of Treatment With a Medicine Called Coramitug (NNC6019-0001) in People With Heart Failure Due to Transthyretin Amyloid (ATTR) AmyloidosisRecruitingNCT07207811Phase 3
• Defeat Rare Disease in Asia and Pacific (APAC) DRDA - HaemophiliaEnrolling by invitationNCT07163260
• A Research Study to See How Safe is Eptacog Alfa When Used to Stop Heavy Bleeding in Women After Giving Birth in IndiaRecruitingNCT07157423Phase 4
• Characteristics and Treatment Experiences of Individuals Using Injectable Semaglutide for Weight Management, a Cross-sectional Time-series Analysis, Multi-country Study.Enrolling by invitationNCT07154238
• Safety Follow-up Study of Participants Dosed With INV-347 in Study INV-CL-108RecruitingNCT07153172Phase 1
• A Research Study to See How Well Weekly Insulin Icodec Maintains Blood Sugar Levels Compared to Daily Basal Insulins in Adults With Type 2 DiabetesRecruitingNCT07112339Phase 4
• A Two-year Prospective, Observational Study of Wegovy in Real-world Clinical PracticeEnrolling by invitationNCT07055607
• A Multicentre, Prospective, Single-arm, Non-interventional Regulatory Post-marketing Surveillance (rPMS) Study to Investigate the Safety and Effectiveness of Wegovy® (Semaglutide) in Patients With Obesity and Patients With Overweight in Routine Clinical Practice in KoreaEnrolling by invitationNCT07018544
• The Role of the Amylin Analogue Cagrilintide in Bone MetabolismRecruitingNCT07010432Phase 1
• A Research Study Comparing CDR132L With Placebo on the Structure and Function of the Heart in People With Heart Failure With Reduced/Mildly Reduced Ejection Fraction and Left Ventricular HypertrophyRecruitingNCT06979375Phase 2
• A Research Study Comparing Different Doses of CDR132L With Placebo on the Structure and Function of the Heart in People With Heart Failure With Preserved Ejection Fraction and Left Ventricular HypertrophyRecruitingNCT06979362Phase 2
• Multiple Dose Study for a New Medication to Potentially Treat Liver DiseasesRecruitingNCT06891365Phase 1
• Cities for Better Health Childhood Obesity Prevention InitiativeEnrolling by invitationNCT06855563Not applicable
• Post-marketing Surveillance (Special Use-results Surveillance) on Treatment With AlhemoEnrolling by invitationNCT06831734
• General Use-results Surveillance With Awiqli in Patients With Diabetes MellitusRecruitingNCT06807190
• A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney DiseaseRecruitingNCT06717698Phase 2
• A Study to Follow Paediatric Participants With Growth Hormone Deficiency Treated With Somapacitan for Long Term Safety Information and Clinical ParametersEnrolling by invitationNCT06709040
• A Study to Evaluate How Well Etavopivat Works in People With Sickle Cell DiseaseRecruitingNCT06612268Phase 3
• A Research Study Looking at Long-term Treatment With Etavopivat in People With Sickle Cell Disease or ThalassaemiaRecruitingNCT06609226Phase 3
• A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASHRecruitingNCT06528314Phase 3
• Safety, Tolerability, and Pharmacokinetics of DCR-PDL1 in Adults With Solid TumorsRecruitingNCT06504368Phase 1
• Post-Marketing Surveillance (All Case Surveillance) on Treatment With Alhemo® in Patients With Haemophilia A or Haemophilia B With InhibitorsEnrolling by invitationNCT06285071
• A Study Evaluating Efruxifermin in Subjects With Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and FibrosisRecruitingNCT06215716Phase 3
• A Study to Evaluate the Pharmacokinetics and Safety of Etavopivat in Pediatric Patients With Sickle Cell DiseaseRecruitingNCT06198712Phase 2
• Special Use-results Surveillance on Long Term Use of Sogroya® in Children With Short Stature Due to Growth Hormone Deficiency Where Epiphysial Discs Are Not ClosedEnrolling by invitationNCT06109935
• A Phase 2 Open-label Study to Evaluate the Activity of Etavopivat on Transcranial Doppler Velocities in Pediatric Patients With Sickle Cell Disease Who Are at Increased Risk for Primary StrokeRecruitingNCT05953584Phase 2
• A Study to Evaluate Safety of Exposure to Wegovy During PregnancyEnrolling by invitationNCT05872022
• An Observational Study of Patients With Moderate Parkinson's DiseaseEnrolling by invitationNCT05779475
• A Study to Follow Patients With Adult Growth Hormone Deficiency (AGHD) Treated With Sogroya® for Long Term Safety InformationEnrolling by invitationNCT05718570
• Regulatory Post Marketing Surveillance (rPMS) Study of Rybelsus (Oral Semaglutide) to Evaluate Safety and Effectiveness in Patients With Type 2 Diabetes Mellitus in Routine Clinical Practice in KoreaNot yet recruitingNCT05714683
• Regulatory Post Marketing Surveillance (rPMS) Study of Ozempic (Semaglutide) to Evaluate Safety and Effectiveness in Patients With Type 2 Diabetes Mellitus in Routine Clinical Practice in KoreaEnrolling by invitationNCT05689372
• A Study to Evaluate the Safety of Exposure to Wegovy During PregnancyEnrolling by invitationNCT05503927
• French Registry of Children Treated With Norditropin® for Short Stature Associated With Noonan SyndromeEnrolling by invitationNCT05308927

← Novo Nordisk A/S overview and focus areas